Psychosocial Aspects of Kidney Transplantation and Living Kidney Donation

Author(s):  
Benson M. Hoffman ◽  
Caroline K. Saulino ◽  
Patrick J. Smith
2021 ◽  
Author(s):  
Kyungok Min ◽  
Tai Yeon Koo ◽  
Young Hui Hwang ◽  
Jaeseok Yang

Abstract Since the waiting time for deceased donor kidney transplantation continues to increase, living donor kidney transplantation is an important treatment for end stage kidney disease patients. Barriers to living kidney donation have been rarely investigated despite a growing interest in the utilization of living donor transplantation and the satisfaction of donor safety. Here, we retrospectively analyzed 1,658 potential donors and 1,273 potential recipients who visited the Seoul National University Hospital for living kidney transplantation between 2010 and 2017 to study the causes of donation failure. Among 1,658 potential donors, 902 (54.4%) failed to donate kidneys. The average number of potential donors that received work-up was 1.30 ± 0.66 per recipient. Among living donor kidney transplant patients, 75.1% received kidneys after work-up of the first donor and 24.9% needed work-up of two or more donors. Donor-related factors (49.2%) were the most common causes of donation failure, followed by immunologic or size mismatches between donors and recipients (25.4%) and recipient-related factors (16.2%). Interestingly, withdrawal of donation will along with refusal by recipients or family were the commonest causes, suggesting the importance of non-biomedical aspects. The elucidation of the barriers to living kidney donation could ensure more efficient and safer living kidney donation.


2008 ◽  
Vol 40 (3) ◽  
pp. 677-681 ◽  
Author(s):  
I.C. Frade ◽  
I. Fonseca ◽  
L. Dias ◽  
A.C. Henriques ◽  
L.S. Martins ◽  
...  

2016 ◽  
Vol 16 (C) ◽  
pp. 90
Author(s):  
Ekamol Tantisattamo ◽  
Weera Sukhumthammarat ◽  
Prapaipan Putthapiban ◽  
Wasawat Vutthikraivit ◽  
Siwadon Pitukweerakul

Nephron ◽  
2020 ◽  
Vol 144 (11) ◽  
pp. 583-588
Author(s):  
Matej Vnučák ◽  
Karol Graňák ◽  
Petra Skálová ◽  
Ľudovít Laca ◽  
Marián Mokáň ◽  
...  

Nephronophthisis (NPHP) is an autosomal recessive disease manifesting as tubulointerstitial nephritis uniformly progressing to ESRD in approximately 5–10% patients in childhood. Living donor transplantation is the most beneficial mean of renal replacement therapy compared to other methods. However, living kidney donation is contraindicated in potential donor with diseases of autosomal dominant mode of inheritance potentially leading to kidney failure in future. On the other hand, autosomal recessive genetic kidney diseases, such as NPHP, are not usually contraindication to living kidney donation. Herein, we are reporting related living kidney transplantation with a family history of NPHP form 46-year-old mother (heterozygote) to 17-year-old daughter with (autosomal recessive homozygote) with focus on donor follow-up after nephrectomy.


2020 ◽  
Vol 95 (4) ◽  
pp. 260-265
Author(s):  
Ha Yeol Park ◽  
Byung Chul Shin

Kidney transplantation is the treatment of choice for end-stage renal disease. A successful kidney transplant improves the quality of life and reduces the mortality risk of patients, as compared to maintenance dialysis. The number of patients awaiting kidney transplantation has steadily increased, and the gap between allograft supply and demand continues to widen despite initiatives to expand the use of nonstandard deceased-donor allografts. The use of organs from living donors is one strategy to address the need for transplants. A medical, surgical, and psychosocial evaluation is mandatory prior to living kidney donation to ensure that the donor candidate is in good health and has normal kidney function, is not a risk to the recipient with respect to transmission of infections and malignancy, and will not face unacceptable risks after donation.


The Physician ◽  
2021 ◽  
Vol 7 (1) ◽  
pp. 1-7
Author(s):  
Ahmed Ahmed ◽  
Anna Winterbottom ◽  
John Stoves ◽  
Shenaz Ahmed ◽  
Sunil Daga

Introduction  Living donor kidney transplantation is the optimal modality of renal replacement therapy for advanced kidney disease. It is associated with superior recipient and graft survival, a better quality of life and self-reported health status compared to dialysis. Living kidney donation occurs less frequently in members of Black, Asian and Minority Ethnic (BAME) communities in Western countries. This scoping review explores the factors affecting the ability of patients (and health professionals) to initiate conversations about living kidney donation with family and friends, with a focus on BAME population groups. Methods  208 published articles were identified from online databases using keywords: ‘barriers’, ‘decision making’, ‘living donor’, and ‘kidney transplantation. Studies limited to donors or involving paediatric recipients were excluded, Results There were 25 studies that met the inclusion criteria. Of these, 21 studies included BAME communities. Participants of South Asian ethnicity were underrepresented. Key themes were; 1) lack of knowledge 2) risk perception 3) fear of financial burden on donors 4) guilt 5) religious and cultural influences and 6) mistrust of the medical establishment. There were noticeable differences in ethnicity, in the level of knowledge, risk perception and fear of financial burden. Religious/cultural reservations and medical mistrust were only reported in people from BAME populations. Two studies explored health professionals’ views. Discussion This literature review has identified different barriers to the pursuit of living kidney donation, some of which are linked to ethnicity. This study informs the development of a patient decision aid to support people to have conversations with potential donors, with a particular focus on South Asian groups, the second largest ethnic group in the UK.


Author(s):  
Emma K. Massey ◽  
Mathilde C. Pronk ◽  
Willij C. Zuidema ◽  
Willem Weimar ◽  
Jacqueline Wetering ◽  
...  

2021 ◽  
Vol 2 (1) ◽  
pp. 75-86
Author(s):  
Maria Irene Bellini ◽  
Vito Cantisani ◽  
Augusto Lauro ◽  
Vito D’Andrea

Living kidney donation represents the best treatment for end stage renal disease patients, with the potentiality to pre-emptively address kidney failure and significantly expand the organ pool. Unfortunately, there is still limited knowledge about this underutilized resource. The present review aims to describe the general principles for the establishment, organization, and oversight of a successful living kidney transplantation program, highlighting recommendation for good practice and the work up of donor selection, in view of potential short- and long-terms risks, as well as the additional value of kidney paired exchange programs. The need for donor registries is also discussed, as well as the importance of lifelong follow up.


2017 ◽  
Vol 44 (5) ◽  
pp. 310-313 ◽  
Author(s):  
Julian Koplin

We do not always benefit from the expansion of our choice sets. This is because some options change the context in which we must make decisions in ways that render us worse off than we would have been otherwise. One promising argument against paid living kidney donation holds that having the option of selling a ‘spare’ kidney would impact people facing financial pressures in precisely this way. I defend this argument from two related criticisms: first, that having the option to sell one’s kidney would only be harmful if one is pressured or coerced to take this specific course of action; and second, that such forms of pressure are unlikely to feature in a legal market.


Sign in / Sign up

Export Citation Format

Share Document